| Literature DB >> 27446611 |
Francisco Elano Carvalho Pereira1, Irene Lopes Mello2, Fernando Heladio de Oliveira Medeiros Pimenta2, Debora Maia Costa2, Deysi Viviana Tenazoa Wong3, Claudia Regina Fernandes1, Roberto César Lima Junior3, Josenília M Alves Gomes1.
Abstract
This study aims to evaluate the viability of a clinical model of remote ischemic preconditioning (RIPC) and its analgesic effects. It is a prospective study with twenty (20) patients randomly divided into two groups: control group and RIPC group. The opioid analgesics consumption in the postoperative period, the presence of secondary mechanical hyperalgesia, the scores of postoperative pain by visual analog scale, and the plasma levels interleukins (IL-6) were evaluated. The tourniquet applying after spinal anesthetic block was safe, producing no pain for all patients in the tourniquet group. The total dose of morphine consumption in 24 hours was significantly lower in RIPC group than in the control group (p = 0.0156). The intensity analysis of rest pain, pain during coughing and pain in deep breathing, showed that visual analogue scale (VAS) scores were significantly lower in RIPC group compared to the control group: p = 0.0087, 0.0119, and 0.0015, respectively. There were no differences between groups in the analysis of presence or absence of mechanical hyperalgesia (p = 0.0704) and in the serum levels of IL-6 dosage over time (p < 0.0001). This clinical model of remote ischemic preconditioning promoted satisfactory analgesia in patients undergoing conventional cholecystectomy, without changing serum levels of IL-6.Entities:
Year: 2016 PMID: 27446611 PMCID: PMC4944064 DOI: 10.1155/2016/5093870
Source DB: PubMed Journal: Pain Res Treat ISSN: 2090-1542
Figure 1Hyperalgesia area.
Figure 2Von Frey filaments. Colors determine the variation of the force produced by applying the filament.
Age, weight, and operative time between groups: expressed as mean values ± standard error of the mean. Analysis: KS test for normal distribution followed by unpaired t-test. p values <0.05 were considered significant.
| Control group | Tourniquet group | |
|---|---|---|
| Age (years) | 38.70 ± 3.422 | 40.80 ± 3.994 |
|
| ||
|
| ||
| Weight (Kg) | 64.60 ± 2.676 | 67.30 ± 3.337 |
|
| ||
|
| ||
| Operative time (min.) | 72.50 ± 3.819 | 67.00 ± 4.667 |
|
| ||
Physical state as ASA. Data expressed as absolute numbers of patients in the respective ASA. p values <0.05 were considered significant. Analysis: Fisher's exact test.
| ASA I | ASA II | |
|---|---|---|
| Control group | 7 | 3 |
| RIPC group | 6 | 4 |
Figure 3Morphine consumption. Values expressed as mean ± standard deviation of the mean. p = 0.0656. Analysis: KS test for normality of distribution followed by Mann-Whitney test. p values <0.05 were considered significant.
Figure 4Intensity of postoperative pain at rest. Values expressed as mean ± standard deviation of the mean. p = 0.0087. Analysis: KS test for normality of distribution followed by Mann-Whitney test. p values <0.05 were considered significant.
Figure 5Intensity of postoperative pain on deep breathing. Values expressed as mean ± standard deviation of the mean. p = 0.0119. Analysis: KS test for normality of distribution followed by Mann-Whitney test. p values <0.05 were considered significant.
Figure 6Intensity of postoperative pain in cough. Values expressed as mean ± standard deviation of the mean. p = 0.0015. Analysis: KS test for normal distribution followed by unpaired t-test. p values <0.05 were considered significant.
Figure 7Values are expressed as mean + standard deviation of the average IL-6 concentration in the blood sample times (T0, T1, T2, and T3). p = 0.0001 for group comparison within the tourniquet over time and p = 0.779 for comparison between groups at the same time. p values <0.05 were considered significant. Analysis: KS test for normal distribution followed by Kruskal-Wallis test.